US Stock MarketDetailed Quotes

SMMT Summit Therapeutics

Watchlist

13.080
-0.440-3.25%

Close Aug 23 16:00 ET

13.150
+0.070+0.54%

Post 20:01 ET

9.48BMarket Cap-118909P/E (TTM)

Summit Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-12.74%-33M

-129.49%-30.13M

-84.60%-76.76M

-474.86%-19.46M

-74.13%-14.9M

-52.33%-29.27M

30.89%-13.13M

42.71%-41.58M

156.55%5.19M

63.70%-8.56M

Net income from continuing operations

-310.31%-60.39M

91.98%-43.47M

-680.54%-614.93M

-90.17%-36.57M

0.55%-21.27M

12.25%-14.72M

-2,434.82%-542.38M

11.08%-78.78M

29.04%-19.23M

-9.11%-21.39M

Operating gains losses

75.97%-124K

101.01%9K

-151.22%-1.34M

73.41%-440K

-73.49%505K

-138.83%-516K

-185.73%-889K

702.45%2.62M

-270.62%-1.66M

123.85%1.91M

Depreciation and amortization

-56.52%20K

-70.00%27K

-18.46%2.05M

1.51%605K

83.85%1.31M

-92.22%46K

-85.37%90K

2.40%2.51M

-11.18%596K

12.66%712K

Other non cash items

----

17,252.47%527.17M

-96.25%82K

195.45%84K

-96.77%24K

266,050.51%526.98M

511.27%3.04M

12,752.94%2.19M

-153.33%-88K

Change In working capital

122.96%3M

2,393.99%4.2M

-127.48%-2.37M

-31.66%8.32M

-65.57%2.58M

-72.04%-13.08M

94.70%-183K

12,959.70%8.62M

14.34%12.17M

190.86%7.5M

-Change in receivables

-390.57%-154K

-47.33%632K

-51.90%4.53M

-101.66%-178K

15,790.91%3.45M

196.36%53K

199.09%1.2M

231.58%9.41M

64.01%10.7M

99.57%-22K

-Change in prepaid assets

172.41%3.55M

-943.50%-2.79M

-117.90%-914K

2,513.86%2.64M

-73.22%1.01M

-237.42%-4.9M

-87.66%331K

117.78%5.11M

-92.11%101K

230.04%3.78M

-Change in payables and accrued expense

125.74%1.77M

198.00%2.16M

-115.45%-349K

301.28%6.59M

-61.46%2.12M

-108.58%-6.86M

-37.84%-2.2M

-65.34%2.26M

-33.09%1.64M

1,727.51%5.5M

-Change in other current assets

80.78%-275K

398.23%2.53M

-1,691.16%-3.42M

87.46%-43K

-224.75%-2.46M

-37.60%-1.43M

237.30%508K

106.73%215K

-284.41%-343K

810.47%1.97M

-Change in other current liabilities

---1.72M

--1.76M

-101.18%-2.21M

-232.69%-692K

-411.45%-1.52M

--0

-2.90%-1.1M

36.00%-208K

-1.71%-297K

-Change in other working capital

-433.33%-160K

-318.18%-92K

----

103.26%48K

99.17%-22K

-795.20%-7.28M

-47.23%276K

-609.99%-3.42M

Cash from discontinued investing activities

Operating cash flow

-12.74%-33M

-129.49%-30.13M

-84.60%-76.76M

-474.86%-19.46M

-74.13%-14.9M

-52.33%-29.27M

30.89%-13.13M

42.71%-41.58M

156.55%5.19M

63.70%-8.56M

Investing cash flow

Cash flow from continuing investing activities

-96,756.52%-200.08M

103.08%19.87M

-94,094.55%-587.77M

605,580.00%60.57M

-17,530.00%-3.49M

170.65%207K

-178,587.81%-645.06M

-103.92%-624K

108.33%10K

400.00%20K

Net PPE purchase and sale

-130.58%-63K

92.45%-4K

115.71%98K

-120.00%-2K

-365.00%-53K

170.31%206K

85.32%-53K

-103.92%-624K

108.33%10K

400.00%20K

Net investment purchase and sale

-20,001,700.00%-200.02M

111.69%19.88M

---112.86M

--60.57M

---3.43M

--1K

---170M

--0

Net other investing changes

----

---475.02M

--0

---475.02M

----

Cash from discontinued investing activities

Investing cash flow

-96,756.52%-200.08M

103.08%19.87M

-94,094.55%-587.77M

605,580.00%60.57M

-17,530.00%-3.49M

170.65%207K

-178,587.81%-645.06M

-103.92%-624K

108.33%10K

400.00%20K

Financing cash flow

Cash flow from continuing financing activities

250,365.00%200.21M

-99.39%485K

-86.05%86.51M

-98.80%6.25M

-99.69%229K

-80K

218.07%80.11M

696.04%620.24M

41,141.87%520.06M

10,994.23%75M

Net issuance payments of debt

--0

-104.75%-24.69M

--0

-198.74%-24.69M

--520M

---25M

Net common stock issuance

----

--5M

----

--0

----

Proceeds from stock option exercised by employees

--212K

-99.54%485K

6.39%106.82M

1,103.85%1.25M

-99.77%229K

--0

56,229.95%105.34M

3,151.26%100.4M

100.14%104K

13,613.42%100.11M

Net other financing activities

----

-299.35%-619K

--0

---80K

---539K

9.88%-155K

-207.32%-44K

----

Cash from discontinued financing activities

Financing cash flow

250,365.00%200.21M

-99.39%485K

-86.05%86.51M

-98.80%6.25M

-99.69%229K

---80K

218.07%80.11M

696.04%620.24M

41,141.87%520.06M

10,994.23%75M

Net cash flow

Beginning cash position

-13.19%61.61M

-88.99%71.43M

803.47%648.61M

-80.49%23.79M

-26.54%42.12M

-8.37%70.97M

803.47%648.61M

8.09%71.79M

51.99%121.97M

-44.54%57.34M

Current changes in cash

-12.77%-32.87M

98.31%-9.78M

-200.00%-578.02M

-90.98%47.36M

-127.31%-18.15M

-49.39%-29.15M

-10,024.15%-578.08M

11,407.82%578.04M

6,634.72%525.26M

390.42%66.46M

Effect of exchange rate changes

-95.90%12K

-108.11%-36K

168.66%839K

-80.22%272K

90.69%-170K

148.43%293K

367.47%444K

-448.15%-1.22M

428.16%1.38M

-621.74%-1.83M

End cash Position

-31.73%28.75M

-13.19%61.61M

-88.99%71.43M

-80.49%23.79M

-26.54%42.12M

-8.37%70.97M

803.47%648.61M

51.99%121.97M

Free cash flow

-12.88%-33.07M

-128.60%-30.14M

-82.17%-76.89M

-474.18%-19.46M

-75.16%-14.95M

-50.14%-29.29M

31.91%-13.18M

42.10%-42.21M

155.93%5.2M

63.77%-8.54M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-12.74%-33M	-129.49%-30.13M	-84.60%-76.76M	-474.86%-19.46M	-74.13%-14.9M	-52.33%-29.27M	30.89%-13.13M	42.71%-41.58M	156.55%5.19M	63.70%-8.56M
Net income from continuing operations	-310.31%-60.39M	91.98%-43.47M	-680.54%-614.93M	-90.17%-36.57M	0.55%-21.27M	12.25%-14.72M	-2,434.82%-542.38M	11.08%-78.78M	29.04%-19.23M	-9.11%-21.39M
Operating gains losses	75.97%-124K	101.01%9K	-151.22%-1.34M	73.41%-440K	-73.49%505K	-138.83%-516K	-185.73%-889K	702.45%2.62M	-270.62%-1.66M	123.85%1.91M
Depreciation and amortization	-56.52%20K	-70.00%27K	-18.46%2.05M	1.51%605K	83.85%1.31M	-92.22%46K	-85.37%90K	2.40%2.51M	-11.18%596K	12.66%712K
Other non cash items	----	----	17,252.47%527.17M	-96.25%82K	195.45%84K	-96.77%24K	266,050.51%526.98M	511.27%3.04M	12,752.94%2.19M	-153.33%-88K
Change In working capital	122.96%3M	2,393.99%4.2M	-127.48%-2.37M	-31.66%8.32M	-65.57%2.58M	-72.04%-13.08M	94.70%-183K	12,959.70%8.62M	14.34%12.17M	190.86%7.5M
-Change in receivables	-390.57%-154K	-47.33%632K	-51.90%4.53M	-101.66%-178K	15,790.91%3.45M	196.36%53K	199.09%1.2M	231.58%9.41M	64.01%10.7M	99.57%-22K
-Change in prepaid assets	172.41%3.55M	-943.50%-2.79M	-117.90%-914K	2,513.86%2.64M	-73.22%1.01M	-237.42%-4.9M	-87.66%331K	117.78%5.11M	-92.11%101K	230.04%3.78M
-Change in payables and accrued expense	125.74%1.77M	198.00%2.16M	-115.45%-349K	301.28%6.59M	-61.46%2.12M	-108.58%-6.86M	-37.84%-2.2M	-65.34%2.26M	-33.09%1.64M	1,727.51%5.5M
-Change in other current assets	80.78%-275K	398.23%2.53M	-1,691.16%-3.42M	87.46%-43K	-224.75%-2.46M	-37.60%-1.43M	237.30%508K	106.73%215K	-284.41%-343K	810.47%1.97M
-Change in other current liabilities	---1.72M	--1.76M	-101.18%-2.21M	-232.69%-692K	-411.45%-1.52M	--0	--0	-2.90%-1.1M	36.00%-208K	-1.71%-297K
-Change in other working capital	-433.33%-160K	-318.18%-92K	----	----	----	103.26%48K	99.17%-22K	-795.20%-7.28M	-47.23%276K	-609.99%-3.42M
Cash from discontinued investing activities
Operating cash flow	-12.74%-33M	-129.49%-30.13M	-84.60%-76.76M	-474.86%-19.46M	-74.13%-14.9M	-52.33%-29.27M	30.89%-13.13M	42.71%-41.58M	156.55%5.19M	63.70%-8.56M
Investing cash flow
Cash flow from continuing investing activities	-96,756.52%-200.08M	103.08%19.87M	-94,094.55%-587.77M	605,580.00%60.57M	-17,530.00%-3.49M	170.65%207K	-178,587.81%-645.06M	-103.92%-624K	108.33%10K	400.00%20K
Net PPE purchase and sale	-130.58%-63K	92.45%-4K	115.71%98K	-120.00%-2K	-365.00%-53K	170.31%206K	85.32%-53K	-103.92%-624K	108.33%10K	400.00%20K
Net investment purchase and sale	-20,001,700.00%-200.02M	111.69%19.88M	---112.86M	--60.57M	---3.43M	--1K	---170M	--0	--0	--0
Net other investing changes	----	----	---475.02M	--0	--0	--0	---475.02M	----	----	----
Cash from discontinued investing activities
Investing cash flow	-96,756.52%-200.08M	103.08%19.87M	-94,094.55%-587.77M	605,580.00%60.57M	-17,530.00%-3.49M	170.65%207K	-178,587.81%-645.06M	-103.92%-624K	108.33%10K	400.00%20K
Financing cash flow
Cash flow from continuing financing activities	250,365.00%200.21M	-99.39%485K	-86.05%86.51M	-98.80%6.25M	-99.69%229K	-80K	218.07%80.11M	696.04%620.24M	41,141.87%520.06M	10,994.23%75M
Net issuance payments of debt	--0	--0	-104.75%-24.69M	--0	--0	--0	-198.74%-24.69M	--520M	--520M	---25M
Net common stock issuance	----	----	--5M	----	----	----	----	--0	----	----
Proceeds from stock option exercised by employees	--212K	-99.54%485K	6.39%106.82M	1,103.85%1.25M	-99.77%229K	--0	56,229.95%105.34M	3,151.26%100.4M	100.14%104K	13,613.42%100.11M
Net other financing activities	----	----	-299.35%-619K	--0	--0	---80K	---539K	9.88%-155K	-207.32%-44K	----
Cash from discontinued financing activities
Financing cash flow	250,365.00%200.21M	-99.39%485K	-86.05%86.51M	-98.80%6.25M	-99.69%229K	---80K	218.07%80.11M	696.04%620.24M	41,141.87%520.06M	10,994.23%75M
Net cash flow
Beginning cash position	-13.19%61.61M	-88.99%71.43M	803.47%648.61M	-80.49%23.79M	-26.54%42.12M	-8.37%70.97M	803.47%648.61M	8.09%71.79M	51.99%121.97M	-44.54%57.34M
Current changes in cash	-12.77%-32.87M	98.31%-9.78M	-200.00%-578.02M	-90.98%47.36M	-127.31%-18.15M	-49.39%-29.15M	-10,024.15%-578.08M	11,407.82%578.04M	6,634.72%525.26M	390.42%66.46M
Effect of exchange rate changes	-95.90%12K	-108.11%-36K	168.66%839K	-80.22%272K	90.69%-170K	148.43%293K	367.47%444K	-448.15%-1.22M	428.16%1.38M	-621.74%-1.83M
End cash Position	-31.73%28.75M	-13.19%61.61M	-88.99%71.43M	-88.99%71.43M	-80.49%23.79M	-26.54%42.12M	-8.37%70.97M	803.47%648.61M	803.47%648.61M	51.99%121.97M
Free cash flow	-12.88%-33.07M	-128.60%-30.14M	-82.17%-76.89M	-474.18%-19.46M	-75.16%-14.95M	-50.14%-29.29M	31.91%-13.18M	42.10%-42.21M	155.93%5.2M	63.77%-8.54M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall